1. Analysis of a registry database for esophageal cancer from high-volume centers in China
- Author
-
Hu Zd, Yibo Gao, Xiao Gm, Chen Lq, Tiehua Rong, Liu Yy, Sihoe A, Ke-Neng Chen, Shi Xt, Gao Wj, Li Y, Fang Wt, Jiao Gg, Li Xf, Guo Sp, Liu Jf, Luo Jh, Zhang K, Xiangning Fu, He J, Yafan Yang, Ding Nn, Jian Hu, Mao Ys, Yu Zt, Mao Wm, Wu Qc, Chuanben Chen, Gao Sg, Yang D, Han Yt, Guan Fs, Liu Sy, Jun-Hui Fu, Tang Lj, Xu Sd, and Qian Wang
- Subjects
Adult ,Male ,China ,Esophageal Neoplasms ,medicine.medical_treatment ,computer.software_genre ,Young Adult ,medicine ,Humans ,Registries ,Thoracotomy ,Stage (cooking) ,Neoadjuvant therapy ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Database ,business.industry ,Incidence (epidemiology) ,Gastroenterology ,Postoperative complication ,General Medicine ,Perioperative ,Middle Aged ,Esophageal cancer ,medicine.disease ,Neoadjuvant Therapy ,Esophagectomy ,Survival Rate ,Radiation therapy ,Carcinoma, Squamous Cell ,Female ,business ,computer - Abstract
Summary Esophageal cancer has a high incidence among malignancies in China, but a comprehensive picture of the status of its surgical management in China has hitherto not been available. A nationwide database has recently been established to address this issue. Method: A National Database was setup through a network platform, and data was collected from 70 high-volume centers (>100 esophagectomies/per year) across China. Data was entered between January 2009 and December 2014, and was analyzed in June 2015 after a minimal follow-up of 6 months for all patients. 8181 patients with complete data who received surgery for primary esophageal cancer on the Database were included in the analysis. Result: In this series, there were 6052 males and 2129 females, with a mean age of 60.5 years (range: 22–90 years). The pathology in 95.5% of patients was squamous cell carcinoma. The pathological stage distribution was 1.2% in stage 0, 2.5% in Ia, 11.5% in Ib, 14.8% in IIa, 36.1% in IIb, 19.3% in IIIa, 8.3% in IIIb, 6.2% in IIIc. 1800 patients (22.0%) with locally advanced disease received preoperative neoadjuvant therapy and 3592 patients (43.9%) underwent postoperative adjuvant chemotherapy and/or radiotherapy. The esophagectomies were performed through left thoracotomy approach in 5870 cases (72.6%), through right chest approach in 2215 cases (27.4%) including right thoracotomy (21.3%) and VATS (6.1%). The 30-day postoperative mortality rate was 0.6% (43 patients), and the overall postoperative complication rate was 11.6% (951 patients). The 1-, 3-, and 5-year overall survival rates were 82.6%, 61.6%, and 52.9%, respectively. Conclusion: This National Registry Database from high-volume centers provides a comprehensive picture of surgical management for esophageal cancer in China for the first time. Squamous cell carcinoma predominates, but there is heterogeneity with respect to the surgical approach and perioperative oncologic management. Overall, surgical mortality and morbidity rates are low, and good survival rates have been achieved due to improvement of surgical treatment technology in recent years.
- Published
- 2019
- Full Text
- View/download PDF